NEW YORK (GenomeWeb) – Molecular diagnostics and life sciences research tools firm Luminex announced today that it will acquire molecular diagnostics company Nanosphere in an all-cash transaction valued at approximately $58 million.

The transaction values Nanosphere at $1.35 per share, Luminex said. The company will also pay or help Nanosphere pay $25 million in debt outstanding as of March 31. Net of acquired cash, the total deal is valued at $72 million. Both companies' boards have unanimously approved the deal, which is expected to close on or before July 1.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.